Skip to main content
PIIIW logo

PIIIW · P3 Health Partners Inc.

Track PIIIW — free
$0.01 0.00 (-3.06%)
Market Cap
$29.84M
Shares
7.26M
Volume · Oct 22 11.08K Avg daily vol (3M) 227.3K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.01 Open$0.01 Day$0.01–0.01 Available close range$0.01–0.02 Avg vol 30d405K Last earningsAug 10, 2026 DataJul 2026–Oct 2026 Filing10-Q · Aug 10

The closing range uses available history since Jul 23, 2026; less than a full year is stored.

Up next

Next earnings call
Nov 8, 2026 Est · unconfirmed · in 2 wks
filed Aug 10, 2026
call held Aug 10, 2026

Guidance & track record

Beat or met 3 of last 3
Latest guidance · from the Earnings Call filed Aug 10, 2026
Adjusted EBITDA · full-year 2026 Non-GAAP Raised $80M – $110M
May 14, 2026 $20M – $60M changed to Aug 10, 2026 $80M – $110M
Guided vs delivered · last 3 settled
Total Revenues full year 2024
guided $1.45B – $1.55B
$1.5B In line
Revenue 2023
guided $1.2B – $1.25B
$1.27B Beat +3.4%
Revenue full-year 2022
guided $1.03B – $1.08B
$1.05B In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
2 of 35 funds reported for Sep 30 · net +758.8K sh shares · +1 new
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Steady
35 holders — mid 3-yr range
Price context
position in its available closing range
Range low $0 Now $0 · 28% Range high $0
vs 50-day avg -9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA (loss) non-GAAP 80.2M Six Months Ended June 30 —
Adjusted EBITDA (loss) PMPM non-GAAP $127 Six Months Ended June 30 —
Adjusted EBITDA PMPM non-GAAP $173 Q2 2026 —
Adjusted operating expense non-GAAP 56.25M Six Months Ended June 30 —
At-risk members 105,000 Q2 2026 —
Average at-risk members 104,800 the three months ended June 30, 2026 filing —
Medical margin non-GAAP 171.46M Six Months Ended June 30 —
Medical margin PMPM non-GAAP $271 Six Months Ended June 30 —
Platform support costs $26.97M the three months ended June 30, 2026 filing —
Platform support costs as % of total operating revenue 7% the three months ended June 30, 2026 filing —
Total lives under management 133,000 Q2 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Care Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PIIIW
P3 Health Partners Inc.
this stock
$29.84M — -2.8% — —
HCA
HCA Healthcare, Inc.
$101.91B +0.1% +7.1% 15.4 2.2%
FSNUY
Fresenius SE & Co. KGaA
$28.97B -10.3% — — 0.0%
THC
Tenet Healthcare Corp
$21.49B +36.2% +0.9% 10.3 2.3%
EHC
Encompass Health Corp
$11.88B +18.7% +10.5% 19.6 3.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
36
% held
79.1%
Reported
2 of 35
Top holder
LMR Partners LLP
Held Float
View
Short & Settlement
Fails to Deliver
FTD shares
1.3K
Value
$9.1K
As of
Sep 25, 2026
View
Financials
Financials
Revenue (FY)
$1.5B
Net income (FY)
$-147.9M
EPS diluted
$-45.26
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 11, 2026
This year
17
View
Earnings & Events
Webcasts
Last webcast
Aug 10, 2026
View

Performance

5D 20D 120D MTD YTD
PIIIW +38.0% +58.1% — +29.0% —
SPY -1.0% -0.4% +6.0% +0.2% +12.0%
vs SPY +39.0% +58.5% — +28.8% —
Key facts CIK 1832511 CUSIP 744413204 13F (30d) 2 filings 2 filers Visit website Investor relations